Literature DB >> 12933587

Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.

Hermann Heimpel1, Volker Anselstetter, Ladislav Chrobak, Jonas Denecke, Beate Einsiedler, Kerstin Gallmeier, Antje Griesshammer, Thorsten Marquardt, Gritta Janka-Schaub, Martina Kron, Elisabeth Kohne.   

Abstract

Congenital dyserythropoietic anemia type II (CDA II) is the most frequent type of congenital dyserythropoietic anemia. More than 200 cases have been described, but with the exception of a report by the International CDA II Registry, these reports include only small numbers of cases and no data on the lifetime evolution of the disease. Since 1967, we were able to follow 48 cases of CDA II from 43 families for up to 35 years. All patients exhibit chronic anemia of variable severity requiring regular red cell transfusions only in a minority of children; 60% developed gallstones before the age of 30 years, and 16 patients had cholecystectomy between 8 and 34 years of age. Iron overload was a frequent complication. In 16 cases, iron depletion started between 7 and 36 years. Three patients died from secondary hemochromatosis. Splenectomy, performed in 22 cases, led to moderate increases in hemoglobin values and eliminated the need for transfusions but did not prevent further iron loading. The current recommendation is to consider splenectomy if the anemia compromises patients' performance, and to manage iron overload according to the guidelines derived from patients with thalassemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933587     DOI: 10.1182/blood-2003-02-0613

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells.

Authors:  Hermann Heimpel; Kerstin Kellermann; Nadine Neuschwander; Josef Högel; Klaus Schwarz
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

2.  Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.

Authors:  Klaus Schwarz; Achille Iolascon; Fatima Verissimo; Nikolaus S Trede; Wyatt Horsley; Wen Chen; Barry H Paw; Karl-Peter Hopfner; Karlheinz Holzmann; Roberta Russo; Maria Rosaria Esposito; Daniela Spano; Luigia De Falco; Katja Heinrich; Brigitte Joggerst; Markus T Rojewski; Silverio Perrotta; Jonas Denecke; Ulrich Pannicke; Jean Delaunay; Rainer Pepperkok; Hermann Heimpel
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

3.  Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Authors:  Ayse Salihoglu; Tugrul Elverdi; Ahmet Emre Eskazan; Deniz Eyice; Isil Bavunoglu; Muhlis Cem Ar; Seniz Ongoren; Elif Guzel; Zafer Baslar; Aydin Tunckale; Nukhet Tuzuner; Teoman Soysal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-21       Impact factor: 0.900

4.  Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B.

Authors:  Rami Khoriaty; Matthew P Vasievich; Morgan Jones; Lesley Everett; Jennifer Chase; Jiayi Tao; David Siemieniak; Bin Zhang; Ivan Maillard; David Ginsburg
Journal:  Mol Cell Biol       Date:  2014-07-28       Impact factor: 4.272

5.  Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan.

Authors:  Maryam Khan; Raheel Iftikhar; Tariq Ghafoor; Fayyaz Hussain; Qamar Un Nisa Chaudhry; Syed Kamran Mahmood; Nighat Shahbaz; Mehreen Ali Khan; Tariq Azam Khattak; Ghassan Umair Shamshad; Jahanzeb Rehman; Sundas Ali; Zunaira Shah; Abdul Rafae; Muhammad Farhan; Faiz Anwer; Parvez Ahmed
Journal:  Bone Marrow Transplant       Date:  2020-11-12       Impact factor: 5.483

6.  Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.

Authors:  Shanshan Chen; Ziwen Guo; Yongbin Ye; Shanhong Yang; Guinian Huang
Journal:  Int J Hematol       Date:  2021-04-29       Impact factor: 2.490

7.  Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).

Authors:  Jonas Denecke; Christian Kranz; Manfred Nimtz; Harald S Conradt; Thomas Brune; Hermann Heimpel; Thorsten Marquardt
Journal:  Glycoconj J       Date:  2007-12-29       Impact factor: 2.916

8.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

9.  Congenital dyserythropoietic anemia type II - a case report of two siblings in a family.

Authors:  Khaidem Ibochouba Singh; Jigme Tenzing Shartsho; Waikhom Ruhini Kumar Singh; Raj Kumari Tamphasana Devi; Ahongshangbam Meina Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

Review 10.  A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis.

Authors:  Themistoklis Vassiliadis; Vassilia Garipidou; Vassilios Perifanis; Konstantinos Tziomalos; Olga Giouleme; Kalliopi Patsiaoura; Michalis Avramidis; Nikolaos Nikolaidis; Sofia Vakalopoulou; Ioannis Tsitouridis; Antonios Antoniadis; Panagiotis Semertzidis; Anna Kioumi; Evangelos Premetis; Nikolaos Eugenidis
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.